- Our Technology
Engineered for fragile biologics. Verified in viable skin
ExoGenis provides the delivery unlock for complex biologics, ensuring they reach the viable skin layer without degradation.
Precision delivery into viable skin
Our dissolvable microneedle interface targets the viable epidermis (80–150 μm) — the optimal zone for biologic uptake. No retained needles, no damage.
Key benefits:
- No retained needles
- Controlled depth (80–150 μm)
- Minimally invasive
- Compatible with clinical workflows and biologics
- Our dissolvable microneedle interface loaded with exosomes
How it works
The patch painlessly creates microchannels that enable delivery of exosomes, peptides, and growth factors into viable skin. Channels close within minutes—designed for minimal downtime.
APPLY
PATCH
Patch is applied to clean, dry skin.
.svg)
CREATE
MICROCHANNELS
Microstructures create uniform microchannels at a precise depth.
DELIVER
BIOLOGICS
Biologics are delivered through the microchannels into the skin.
PATCH
DISSOLVES
Channels close within minutes. Designed for minimal downtime.
One platform. Multiple biologics. Multiple indications.
ExoGenis is built around a biologic-compatible, dissolvable microneedle patch that serves as a configurable delivery platform.
The same patch architecture can be paired with different biologic payloads, indications, and clinical use cases without redesigning the delivery system.
current focus
Exosomes
Extracellular vesicles for regenerative and maintenance skin applications.
IN development
Growth factors
Precise placement for tissue regeneration and repair.
IN development
Peptides
Bioactive peptides that are unstable or ineffective when applied topically.
research phase
Vaccines (Future)
Intradermal delivery for immunologic applications.
future focus
Complex proteins
Larger biologic molecules that cannot penetrate the skin barrier.
future focus
Combination therapies
Layered or sequential delivery on the same platform.
We build delivery infrastructure, not cosmetic SKUs.
Injection-free micro-channel formation, depth-controlled placement, and preserved biologic integrity — verified on bench, with pilot manufacturing underway.
Repeatable release kinetics. Designed to integrate with the actives you already trust.
From prototype → clinical adoption
Built on validated technology, now moving into clinical deployment with partner clinics
MVP & prototyping
Completed
Core delivery system built and functionally validated.
Technical validation
ongoing
Reproducibility, stability, and performance testing ongoing.
Pilot manufacturing
next
Scale-up and manufacturing readiness in progress.
Clinical pilots
planned
Clinical deployment with partner clinics (2026).
Interested in partnering with us?
We collaborate with aesthetic manufacturers and pharmaceutical labs to integrate our delivery system with your active ingredients.